This may be related to some cardiac causes after acute myocardial infarction (such as stent thrombosis, recurrent myocardial infarction, mechanical complications, and scar-related ventricular arrhythmias) and non-cardiac causes within the first 30 days, which cannot be altered by SGLT2 inhibitors. The gene discussed is SLC5A2; the disease is myocardial infarction.